Oklahoma 2022 Regular Session

Oklahoma Senate Bill SB861

Introduced
2/1/21  
Refer
2/2/21  
Report Pass
2/28/22  
Engrossed
3/23/22  
Refer
3/30/22  
Report Pass
4/14/22  
Enrolled
5/2/22  

Caption

Health insurance; requiring health benefit plans to administer certain coverage. Effective date.

Impact

The passage of SB861 is expected to have significant repercussions on state health laws by ensuring that critical diabetes management resources are covered by insurance plans. This legislative action signifies a broader commitment to improving public health outcomes, aiming to reduce the economic and personal burdens associated with diabetes. Furthermore, the mandatory immunization coverage reflects an intent to boost childhood vaccination rates, which can lead to long-term benefits for community health overall.

Summary

Senate Bill 861 aims to amend existing laws pertaining to health benefit plans in Oklahoma, specifically focusing on enhancing coverage for diabetes treatment and child immunization. The bill mandates that health benefit plans must provide certain essential treatments and supplies for diabetes, including equipment like blood glucose monitors, insulin, and testing supplies, thereby addressing the medical needs of individuals with diabetes. In addition, it enforces that immunizations for children must be fully covered without any cost-sharing, effectively making preventive healthcare more accessible to families.

Sentiment

The sentiment around SB861 is generally positive among health advocates and medical professionals, who see the bill as a necessary step towards providing comprehensive care for chronic conditions like diabetes. Proponents laud the bill for improving patient access to vital health services that can prevent complications. Conversely, there may be some opposition from insurance companies concerned about the broader financial implications of mandated coverage and the potential costs associated with expanded benefits and services.

Contention

While SB861 has garnered support, notable points of contention could arise regarding the bill's implications for insurance providers, particularly with respect to the caps placed on insulin pricing and the requirement for comprehensive coverage of diabetes-related services. Some concerns center around the feasibility of enforcing these requirements across all health plans and the financial strain they might impose on insurance carriers. Nonetheless, the overarching goal remains to balance healthcare accessibility with economic viability.

Companion Bills

No companion bills found.

Previously Filed As

OK SB143

Health insurance; requiring certain high deductible health plans to allow an insured to set aside funds for medical expenses subject to certain limitations. Effective date.

OK SB143

Health insurance; requiring certain high deductible health plans to allow an insured to set aside funds for medical expenses subject to certain limitations. Effective date.

OK HB1019

Health insurance; diabetes treatment; insulin cost; effective date.

OK SB990

Health insurance; requiring certain private insurance plans allow setting aside certain monies. Effective date.

OK HB3978

Health insurance; diabetes treatment; coverage requirements; effective date.

OK HB2351

Health insurance; definitions; treatment of diabetes; Insurance Department and the State Department of Health to purchase insulin at discounted prices; program that allows Oklahomans to purchase discounted insulin; codification; effective date.

OK HB2351

Health insurance; definitions; treatment of diabetes; Insurance Department and the State Department of Health to purchase insulin at discounted prices; program that allows Oklahomans to purchase discounted insulin; codification; effective date.

OK HB2550

Insurance; health benefit plans; treatment of diabetes; insulin copays; monthly cap; Insurance Commissioner; enforcement; rules; effective date.

OK HB3979

Health insurance; diabetes plan requirements; effective date.

OK SB142

Health insurance; modifying copayment cap of certain insulin supply; requiring copayment cap for certain diabetes equipment and supplies; requiring reduction in cost-sharing amount for certain supply and equipment. Effective date.

Similar Bills

No similar bills found.